by Eric Christianson | Jul 30, 2025 | Endocrine Medication and Disease State Clinical Pearls
Ertugliflozin was first approved in 2017 for the treatment of type 2 diabetes. This medication is an SGLT2 inhibitor that prevents the resorption of glucose back into systemic circulation. It has been shown to be effective in lowering A1c and managing diabetes. In...
by Eric Christianson | Jul 27, 2025 | Women’s and Men’s Health Medication and Disease State Clinical Pearls
Benign prostatic hyperplasia (BPH) is one of those conditions that creeps up with age and quietly causes a whole bunch of problems—especially when medications make it worse. A patient might come in complaining of frequent urination, a weak stream, or feeling like they...
by Eric Christianson | Jul 23, 2025 | Gastrointestinal Case Studies
I think I’ve seen this scenario play out more times than I would like. A patient is prescribed both a laxative, Senna, and Questran (cholestyramine), a medication used to manage diarrhea symptoms. This example of the prescribing cascade often presents slowly...
by Eric Christianson | Jul 20, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
Direct oral anticoagulants (DOACs) are widely used in a variety of conditions, including atrial fibrillation, pulmonary embolism, and deep vein thrombosis. Most DOACs are metabolized by CYP3A4 and utilize the P-glycoprotein (P-gp) transporter. Thus, common...
by Eric Christianson | Jul 16, 2025 | Polypharmacy Cases And The Prescribing Cascade
Counteracting drug effects are all too common in geriatric and polypharmacy patients. I wanted to share common examples that I’ve seen in my practice as a clinical pharmacist. NSAIDs vs. AntihypertensivesCase: A 68-year-old man with hypertension controlled on...
